Loading stock data…
Alpha Teknova (TKNO)
$5.83+0.07 (+1.30%)
Market OpenUpdated 3:07 PM EDT
Alpha Teknova, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alpha Teknova, Inc. in the Healthcare sector is trading at $5.83 with a market capitalization of $233M. Wall Street consensus targets $9.00 (3 analysts), implying a +54.5% move over the next 12 months. The stock is currently near its 52-week high of $6.68, remaining 46.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +54.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.08M↑ | $9.98M↓ | $10.45M↑ | $10.29M↑ | $9.79M |
| Gross Profit | $3.78M↑ | $3.24M↑ | $3.21M↓ | $3.98M↑ | $3.01M |
| Operating Income | -$4.30M↑ | -$4.61M↓ | -$4.02M↓ | -$3.39M↑ | -$4.96M |
| Net Income | -$4.55M↑ | -$4.76M↓ | -$4.29M↓ | -$3.57M↑ | -$4.64M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured me...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$233.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-26.44%
Volume
Today's trading volume
85,069
Recent News
May 2026's Promising Penny Stocks To Watch
The United States market has shown a positive trend, with a 1.3% increase over the last week and a 28% rise over the past year, alongside an anticipated annual earnings growth of 17%. Investing in penny stocks — once considered more mainstream but now seen as niche — can still offer access to potential growth opportunities, particularly in smaller or newer companies. We've identified three penny stocks that demonstrate strong financial health and long-term potential, offering investors a...
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
As you might know, Alpha Teknova, Inc. ( NASDAQ:TKNO ) just kicked off its latest first-quarter results with some very...
Alpha Teknova Q1 Earnings Call Highlights
Alpha Teknova (NASDAQ:TKNO) reported first-quarter 2026 results that management said were largely in line with expectations, highlighted by double-digit revenue growth and a sharp increase in its Clinical Solutions business. President and CEO Stephen Gunstream said the company saw “a relatively stra
Alpha Teknova, Inc. Q1 2026 Earnings Call Summary
Moby summary of Alpha Teknova, Inc.'s Q1 2026 earnings call
Alpha Teknova (TKNO) Q1 2026 Earnings Transcript
With me on today's call are Stephen Gunstream, Alpha Teknova, Inc.'s President and Chief Executive Officer, and Matthew C. Lowell, Alpha Teknova, Inc.'s Chief Financial Officer, who will make prepared remarks and then take your questions. Non-GAAP financial measures should always be considered only as a supplement to, and not as a substitute for or as superior to, financial measures prepared in accordance with GAAP.